Literature DB >> 16896892

The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil.

Iguaracyra Araujo1, Achiléa Lisboa Bittencourt, Helenemarie S Barbosa, Eduardo Martins Netto, Núbia Mendonça, Hans-Dieter Foss, Michael Hummel, Harald Stein.   

Abstract

Pediatric Hodgkin lymphoma (HL) occurring in developing regions is different from HL in industrialized countries due to the higher frequency of association with Epstein-Barr virus (EBV) infection. This infection is related to classical HL (cHL) but is virtually absent in nodular lymphocyte predominant HL (nLPHL). We studied the phenotype and the expression of EBV gene products in 90 pediatric cases by immunohistochemistry and in situ hybridization. EBV-positive tumor cells were found exclusively in cHL. The infection occurred with high frequency in all cHL subtypes, but it predominated in the mixed cellularity and lymphocyte depletion subtypes. These results reinforce the hypothesis that EBV plays a major role in the etiology of pediatric cHL in developing areas. Curiously, the frequency of EBV infection in HL was identical to the previously described for Burkitt's lymphoma in the same pediatric population. As both lymphomas have a postulated precursor cell in the germinal center (GC), the pattern of latently EBV-infected GC cells previously described in Bahia may be related to the development of these lymphomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896892     DOI: 10.1007/s00428-006-0244-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

1.  Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease.

Authors:  H Herbst; E Steinbrecher; G Niedobitek; L S Young; L Brooks; N Müller-Lantzsch; H Stein
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

2.  Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

Authors:  S L Glaser; R J Lin; S L Stewart; R F Ambinder; R F Jarrett; P Brousset; G Pallesen; M L Gulley; G Khan; J O'Grady; M Hummel; M V Preciado; H Knecht; J K Chan; A Claviez
Journal:  Int J Cancer       Date:  1997-02-07       Impact factor: 7.396

3.  Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype.

Authors:  Kung-Chao Chang; Nguyen Thi Khen; Dan Jones; Ih-Jen Su
Journal:  Hum Pathol       Date:  2005-07       Impact factor: 3.466

4.  Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies.

Authors:  H Stein; K Gatter; H Asbahr; D Y Mason
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

5.  Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.

Authors:  J Tamaru; M Hummel; T Marafioti; B Kalvelage; L Leoncini; C Minacci; P Tosi; D Wright; H Stein
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

6.  Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.

Authors:  I Anagnostopoulos; H Herbst; G Niedobitek; H Stein
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

7.  The association between Epstein-Barr virus and Chinese Hodgkin's disease.

Authors:  X G Zhou; S J Hamilton-Dutoit; Q H Yan; G Pallesen
Journal:  Int J Cancer       Date:  1993-09-30       Impact factor: 7.396

8.  Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States.

Authors:  R F Ambinder; P J Browning; I Lorenzana; B G Leventhal; H Cosenza; R B Mann; E M MacMahon; R Medina; V Cardona; S Grufferman
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

Review 9.  Epstein-Barr virus and carcinomas.

Authors:  G Niedobitek; H Herbst; L S Young
Journal:  Int J Clin Lab Res       Date:  1993

10.  Epstein-Barr virus expression in Hodgkin's lymphoma in Kuwait.

Authors:  R R Makar; T Saji; T A Junaid
Journal:  Pathol Oncol Res       Date:  2003-10-07       Impact factor: 3.201

View more
  7 in total

1.  Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt.

Authors:  Josée Audouin; Jacques Diebold; Bharat Nathwani; Elia Ishak; Kenneth Maclennan; Hans Konrad Mueller-Hermelink; James O Armitage; Dennis D Weisenburger
Journal:  J Hematop       Date:  2010-05-28       Impact factor: 0.196

2.  Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma.

Authors:  Gabriela Gualco; Eduardo M Queiroga; Lawrence M Weiss; Claudete E N Klumb; William J Harrington; Carlos E Bacchi
Journal:  Hum Pathol       Date:  2009-01-13       Impact factor: 3.466

Review 3.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

4.  Pediatric lymphomas in Brazil.

Authors:  Gabriela Gualco; Claudete E Klumb; Glen N Barber; Lawrence M Weiss; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China.

Authors:  Xin Huang; Ilja Nolte; Zifen Gao; Hans Vos; Bouke Hepkema; Sibrand Poppema; Anke van den Berg; Arjan Diepstra
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

Review 6.  A new hypothesis for the cancer mechanism.

Authors:  Xiaolong Meng; Jie Zhong; Shuying Liu; Mollianne Murray; Ana M Gonzalez-Angulo
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

7.  Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population.

Authors:  Antonio Hugo Jose Froes Marques Campos; Adriana Moreira; Karina Braga Ribeiro; Roberto Pinto Paes; Maria Claudia Zerbini; Vera Aldred; Carmino Antonio de Souza; Cristovam Scapulatempo Neto; Fernando Augusto Soares; Jose Vassallo
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.